UGR scientists have demonstrated the efficacy and viability of the artificial skin UGRSKIN, an advanced therapy medicinal product (ATMP) they developed in 2012, which has proven to be highly beneficial in the treatment of patients with major burns. Moreover, it does not cause any side effects or significant complications.
Despite enormous medical advances, severe burns are still potentially life-threatening injuries. Clinical scores, which take relevant parameters into account, are available to doctors as a decision-making aid for therapeutic measures and to assess the probability of patient survival.